# Oral Dosage Form New Animal Drugs; Deracoxib
> **Food and Drug Administration** · Final rule. · Published 2008-06-13 · Effective 2008-06-13 · 73 FR 33691
## Document
- **Document number:** E8-13353
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 73 FR 33691
- **CFR reference:** 21 CFR 520
- **Publication date:** 2008-06-13
- **Effective date:** 2008-06-13
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for the addition of a 50-milligram size deracoxib tablet which is used for the control of pain and inflammation in dogs.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2008/06/13/E8-13353/oral-dosage-form-new-animal-drugs-deracoxib)
---
*AI Analytics · CC0 1.0*